PhRMA, others act as Rx drug abuse grows

11 April 2001

The Pharmaceutical Research & Manufacturers of America and six otherorganizations have joined with the National Institute on Drug Abuse in a new campaign against prescription drug abuse and misuse. In 1999, such practices are estimated to have affected up to 4 million people aged over 12, half of whom said they were abusing medications for the first time, and this shows that the abuse is growing, says the NIDA.

The government's National Household Survey on Drug Abuse notes that, in 1999, 1.6 million people said they had used prescription drugs such as painkillers and stimulants for non-medical uses, compared with under 500,000 a year in the late 1980s, and a study published recently in the Journal of the American Pharmaceutical Association estimated that such drug abuse and misuse costs the US health system $177 billion a year.

The problem is particularly acute among seniors, up to 17% of whom could be affected, and women, who are two to three times more likely to be prescribed drugs for depression and thus are more likely to misuse and abuse narcotics and anxiolytics. There has also been a 37% rise in emergency room admissions for teenagers and adolescents following overdoses of painkillers such as Purdue Pharma's OxyContin (oxycodone HCl).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight